Targeting the apoE/ABeta Interaction as a Novel AD Therapy

将 apoE/Aβ 相互作用作为一种新型 AD 疗法

基本信息

项目摘要

DESCRIPTION (provided by applicant): Our main hypothesis is that a therapeutic agent blocking the interaction between apolipoprotein E and B-amyloid will be effective in reducing and preventing 6-amyloid ( AB ) related pathology of Alzheimer's disease (AD).The B-amyloid ( AB ) cascade hypothesis maintains that accumulation of the AB peptide constitutes a critical event in the early pathogenesis of AD. An excess of AB assembles into toxic oligomers and subsequently into deposits in the brain's parenchyma and in walls of vessels producing cerebral amyloid angiopathy (CAA).The direct binding between AB and apolipoprotein E (apoE) has been identified as an important factor promoting the deposition of AB in the CMS and regulating its clearance across the blood-brain-barrier (BBB).The magnitude of apoE/AB interaction appears to be isoform specific, providing one explanation for the linkage between the apoE4 allele and an increased risk of sporadic AD. We have demonstrated that blocking the apoE/AB binding with a synthetic peptide - AB 12-28P, that mimics the apoE binding site on AB and was modified for in vivo application, reduces the burden of parenchynal AB deposits and CAA, as well as preventing memory impairment in AD transgenic (Tg) mice (Sadowski et al. AJP, 2004; 165:937; Sadowski et al., PNAS, 2006; 103:18787). In contrast, anti- AB vaccination approaches prevent only parenchymal AB deposition without affecting the CAA burden. In addition, vaccination appears to increase the risk of perivascular hemorrhages which were absent in AD Tg animals treated with AB 12-28P. In this grant proposal, we are planning to develop non-toxic peptidomimetic antagonists of the apoE/ AB interaction which will be based on the AB 12-28 sequence. The objectives are to improve therapeutic efficacy, BBB penetration, and biostability. Due to the inherent biomimetic character of peptidomimetics, their resistance to degradation, and ease of chemical modification, this strategy has been successfully employed in the past to develop a number of therapeutically promising compounds. Selected peptidomimetic compounds will be tested in AD Tg models including those expressing differing human apoE isoforms. This will be done to predict the therapeutic response in carriers of the various human apoE isoforms. To determine whether this form of therapy can lead to a reduction of already existing AB deposits we will perform in vivo imaging of AB plaques in AD Tg mice using transcranial two-photon microscopy. Although the primary goal of blocking the apoE/ AB interaction is to prevent AB fibrillar assembly and deposition there are also several other potential benefits of this approach which we investigate in this application. Thus, we will determine the effect of blocking the apoE/ AB interaction on AB and apoE clearance across the BBB, the equilibrium between AB oligomers and fibril formation, and intraneuronal accumulation of apoE/ AB complexes. The overall goal of this proposal is to bring this novel therapeutic approach closer to clinical studies and to identify a lead peptidomimetic compound, which could be further developed for safe, long-term application in humans
描述(申请人提供):我们的主要假设是阻断载脂蛋白E和B-淀粉样蛋白之间的相互作用的治疗剂将有效地减少和预防6-淀粉样蛋白(AB)相关的阿尔茨海默病(AD)的病理。B-淀粉样蛋白(AB)级联假说认为AB肽的积聚在AD的早期发病机制中是一个关键事件。过量的AB聚集成有毒的寡聚体,随后沉积在脑实质和血管壁上,导致脑淀粉样血管病(CAA)。AB与载脂蛋白E(ApoE)的直接结合已被认为是促进AB在CMS中沉积并调节其跨血脑屏障(BBB)清除的重要因素。apoE/AB相互作用的大小似乎是异构体特异性的,这为apoE4等位基因与散发性AD风险增加之间的联系提供了一种解释。我们已经证明,用模拟AB上apoE结合部位的合成肽-AB12-28P阻断apoE/AB结合,并进行体内应用,可以减少实质性AB沉积和CAA的负担,并防止AD转基因(TG)小鼠的记忆障碍(Sadowski等人)。AJP,2004年;165.937;Sadowski等人,PNAS,2006年;第103:18787)。相反,抗AB疫苗接种方法只防止实质性AB沉积,而不影响CAA负担。此外,接种疫苗似乎增加了血管周围出血的风险,这在使用AB12-28P治疗的AD TG动物中是没有的。在这项拨款建议中,我们计划开发基于AB 12-28序列的apoE/AB相互作用的无毒模拟肽拮抗剂。其目的是提高治疗效果、血脑屏障渗透率和生物稳定性。由于多肽类药物固有的仿生特性、抗降解和易于化学修饰,这一策略在过去已被成功地应用于开发出许多具有治疗前景的化合物。选定的模拟多肽化合物将在AD TG模型中进行测试,包括那些表达不同人类载脂蛋白E亚型的模型。这将用于预测不同人类载脂蛋白E亚型携带者的治疗反应。为了确定这种治疗形式是否可以减少已经存在的AB沉积,我们将使用经颅双光子显微镜对AD TG小鼠的AB斑块进行体内成像。虽然阻断apoE/AB相互作用的主要目标是防止AB纤维的组装和沉积,但我们在这一应用中也研究了这种方法的其他几个潜在好处。因此,我们将确定阻断apoE/AB相互作用对AB和apoE跨血脑屏障清除的影响,AB寡聚体和纤维形成之间的平衡,以及apoE/AB复合体在神经元内的积累。这项建议的总体目标是使这种新的治疗方法更接近临床研究,并确定一种先导性多肽化合物,该化合物可以进一步开发用于安全的、长期的人类应用。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MARTIN Joseph SADOWSKI其他文献

MARTIN Joseph SADOWSKI的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MARTIN Joseph SADOWSKI', 18)}}的其他基金

Role of Microglia in Neurodegeneration -Effect of ApoE
小胶质细胞在神经退行性变中的作用 - ApoE 的作用
  • 批准号:
    10370582
  • 财政年份:
    2022
  • 资助金额:
    $ 13.5万
  • 项目类别:
Role of Microglia in Neurodegeneration -Effect of ApoE
小胶质细胞在神经退行性变中的作用 - ApoE 的作用
  • 批准号:
    10631864
  • 财政年份:
    2022
  • 资助金额:
    $ 13.5万
  • 项目类别:
Mechanisms of Peroxiredoxin 6 Endowed Protection in Alzheimer’s Disease
过氧化还原蛋白 6 对阿尔茨海默病的保护机​​制
  • 批准号:
    9975324
  • 财政年份:
    2020
  • 资助金额:
    $ 13.5万
  • 项目类别:
Mechanisms of Peroxiredoxin 6 Endowed Protection in Alzheimer’s Disease
过氧化还原蛋白 6 对阿尔茨海默病的保护机​​制
  • 批准号:
    10343791
  • 财政年份:
    2020
  • 资助金额:
    $ 13.5万
  • 项目类别:
Mechanisms of Peroxiredoxin 6 Endowed Protection in Alzheimer’s Disease
过氧化还原蛋白 6 对阿尔茨海默病的保护机​​制
  • 批准号:
    10551833
  • 财政年份:
    2020
  • 资助金额:
    $ 13.5万
  • 项目类别:
Mechanisms of Apolipoprotein E Isoform Conferred Susceptibility and Resistance to Alzheimer's Disease
载脂蛋白 E 同工型赋予阿尔茨海默病易感性和抵抗力的机制
  • 批准号:
    9312725
  • 财政年份:
    2016
  • 资助金额:
    $ 13.5万
  • 项目类别:
Mechanisms of Apolipoprotein E Isoform Conferred Susceptibility and Resistance to Alzheimer's Disease
载脂蛋白 E 同工型赋予阿尔茨海默病易感性和抵抗力的机制
  • 批准号:
    9912080
  • 财政年份:
    2016
  • 资助金额:
    $ 13.5万
  • 项目类别:
Mechanisms of Apolipoprotein E Isoform Conferred Susceptibility and Resistance to Alzheimer's Disease
载脂蛋白 E 同工型赋予阿尔茨海默病易感性和抵抗力的机制
  • 批准号:
    9193845
  • 财政年份:
    2016
  • 资助金额:
    $ 13.5万
  • 项目类别:
Peptoid Antagonists of the ApoE/ABeta Interaction as a Novel Anti-ABeta Therapy.
ApoE/Aβ 相互作用的类肽拮抗剂作为一种新型抗 Aβ 疗法。
  • 批准号:
    8742110
  • 财政年份:
    2013
  • 资助金额:
    $ 13.5万
  • 项目类别:
Peptoid Antagonists of the ApoE/ABeta Interaction as a Novel Anti-ABeta Therapy
ApoE/Aβ 相互作用的类肽拮抗剂作为新型抗 Aβ 疗法
  • 批准号:
    8509559
  • 财政年份:
    2009
  • 资助金额:
    $ 13.5万
  • 项目类别:

相似海外基金

RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
  • 批准号:
    2327346
  • 财政年份:
    2024
  • 资助金额:
    $ 13.5万
  • 项目类别:
    Standard Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
  • 批准号:
    2312555
  • 财政年份:
    2024
  • 资助金额:
    $ 13.5万
  • 项目类别:
    Standard Grant
How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
  • 批准号:
    BB/Z514391/1
  • 财政年份:
    2024
  • 资助金额:
    $ 13.5万
  • 项目类别:
    Training Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
  • 批准号:
    ES/Z502595/1
  • 财政年份:
    2024
  • 资助金额:
    $ 13.5万
  • 项目类别:
    Fellowship
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
  • 批准号:
    ES/Z000149/1
  • 财政年份:
    2024
  • 资助金额:
    $ 13.5万
  • 项目类别:
    Research Grant
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
  • 批准号:
    23K24936
  • 财政年份:
    2024
  • 资助金额:
    $ 13.5万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
  • 批准号:
    2901648
  • 财政年份:
    2024
  • 资助金额:
    $ 13.5万
  • 项目类别:
    Studentship
ERI: Developing a Trust-supporting Design Framework with Affect for Human-AI Collaboration
ERI:开发一个支持信任的设计框架,影响人类与人工智能的协作
  • 批准号:
    2301846
  • 财政年份:
    2023
  • 资助金额:
    $ 13.5万
  • 项目类别:
    Standard Grant
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
  • 批准号:
    488039
  • 财政年份:
    2023
  • 资助金额:
    $ 13.5万
  • 项目类别:
    Operating Grants
How motor impairments due to neurodegenerative diseases affect masticatory movements
神经退行性疾病引起的运动障碍如何影响咀嚼运动
  • 批准号:
    23K16076
  • 财政年份:
    2023
  • 资助金额:
    $ 13.5万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了